You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
|
|---|---|
| Published in |
Molecular Cancer, September 2010
|
| DOI | 10.1186/1476-4598-9-229 |
| Pubmed ID | |
| Authors |
Chun-Zhi Zhang, Jun-Xia Zhang, An-Ling Zhang, Zhen-Dong Shi, Lei Han, Zhi-Fan Jia, Wei-Dong Yang, Guang-Xiu Wang, Tao Jiang, Yong-Ping You, Pei-Yu Pu, Jin-Quan Cheng, Chun-Sheng Kang |
| Abstract |
MiR-221 and miR-222 (miR-221/222) are frequently up-regulated in various types of human malignancy including glioblastoma. Recent studies have reported that miR-221/222 regulate cell growth and cell cycle progression by targeting p27 and p57. However the underlying mechanism involved in cell survival modulation of miR-221/222 remains elusive. |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| France | 1 | <1% |
| Switzerland | 1 | <1% |
| United States | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 106 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 25 | 22% |
| Student > Master | 17 | 15% |
| Researcher | 16 | 14% |
| Student > Bachelor | 11 | 10% |
| Student > Postgraduate | 7 | 6% |
| Other | 21 | 19% |
| Unknown | 15 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 35 | 31% |
| Medicine and Dentistry | 23 | 21% |
| Biochemistry, Genetics and Molecular Biology | 21 | 19% |
| Neuroscience | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 9 | 8% |
| Unknown | 17 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2016.
All research outputs
#6,414,688
of 22,790,780 outputs
Outputs from Molecular Cancer
#447
of 1,719 outputs
Outputs of similar age
#29,717
of 94,306 outputs
Outputs of similar age from Molecular Cancer
#7
of 19 outputs
Altmetric has tracked 22,790,780 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,306 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.